Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1353458

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1353458

LAMEA Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Pruritus Therapeutics Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).

The potential for the creation of innovative therapeutics for pruritus is significant. Exploration in targeted medicines, biologics, and gene therapies provides promise for more specialized and effective treatment alternatives. Because of the increased prevalence of illnesses associated with pruritus, the expanding healthcare infrastructure, and the rising cost of healthcare, the market offers considerable potential in emerging markets.

The skin condition known as urticaria, also called hives, is highly prevalent and establishes millimeter- to centimeter-sized red, itchy lumps on the skin. They can appear in any area of the body. Most allergists recommend antihistamines like cetirizine, fexofenadine, and loratadine to treat urticaria symptoms. The monitoring and managing pruritus can also be improved by integrating digital health technology, including telemedicine, smartphone apps, and wearables. These technologies offer possibilities for real-time data gathering for research goals, customized therapies, and remote patient monitoring. Topical medications such as corticosteroids, antihistamines, and calcineurin inhibitors are usually recommended for mild to severe pruritus. These drugs serve by calming the skin's inflammation, suppressing itch sensations, and hydrating the skin.

The varying tropical, temperate, and frigid temperatures in Latin American nations may directly affect the prevalence of A.D. According to a Brazilian study, 23% of adult A.D. patients and 39% of those with severe depression also had moderate-to-severe depression. According to the "Healthcare Resource Utilization and Direct Cost of Patients with Atopic Dermatitis in Dubai, United Arab Emirates: A Retrospective Cohort Study," AD is a common skin condition in Dubai (UAE) with a 4-5% prevalence rate. Most patients (about 90%) receive specialized care for their situation. According to estimates, the region's high AD prevalence will help increase the regional market.

The Brazil market dominated the LAMEA Pruritus Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $211.6 million by 2030. The Argentina market is estimated to grow at a CAGR of 6.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 5.8% during (2023 - 2030).

Based on Disease Type, the market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria and Others. Based on Product, the market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bristol Myers Squibb Company, Novartis AG, Pfizer, Inc., Sanofi S.A., Astellas Pharma, Inc., Cara Therapeutics, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceuticals Industries Ltd., Amgen, Inc., and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

  • Atopic Dermatitis
  • Allergic Contact Dermatitis
  • Urticaria
  • Others

By Product

  • Corticosteroids
  • Antihistamines
  • Local Anesthetics
  • Counterirritants
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Bristol Myers Squibb Company
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Astellas Pharma, Inc.
  • Cara Therapeutics, Inc.
  • GlaxoSmithKline PLC (GSK)
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • AbbVie, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Pruritus Therapeutics Market, by Disease Type
    • 1.4.2 LAMEA Pruritus Therapeutics Market, by Product
    • 1.4.3 LAMEA Pruritus Therapeutics Market, by Distribution Channel
    • 1.4.4 LAMEA Pruritus Therapeutics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. LAMEA Pruritus Therapeutics Market by Disease Type

  • 4.1 LAMEA Atopic Dermatitis Market by Country
  • 4.2 LAMEA Allergic Contact Dermatitis Market by Country
  • 4.3 LAMEA Urticaria Market by Country
  • 4.4 LAMEA Others Market by Country

Chapter 5. LAMEA Pruritus Therapeutics Market by Product

  • 5.1 LAMEA Corticosteroids Market by Country
  • 5.2 LAMEA Antihistamines Market by Country
  • 5.3 LAMEA Local Anesthetics Market by Country
  • 5.4 LAMEA Counterirritants Market by Country
  • 5.5 LAMEA Immunosuppressant Market by Country
  • 5.6 LAMEA Calcineurin Inhibitors Market by Country
  • 5.7 LAMEA Others Market by Country

Chapter 6. LAMEA Pruritus Therapeutics Market by Distribution Channel

  • 6.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
  • 6.2 LAMEA Hospital Pharmacies Market by Country
  • 6.3 LAMEA Online Providers Market by Country

Chapter 7. LAMEA Pruritus Therapeutics Market by Country

  • 7.1 Brazil Pruritus Therapeutics Market
    • 7.1.1 Brazil Pruritus Therapeutics Market by Disease Type
    • 7.1.2 Brazil Pruritus Therapeutics Market by Product
    • 7.1.3 Brazil Pruritus Therapeutics Market by Distribution Channel
  • 7.2 Argentina Pruritus Therapeutics Market
    • 7.2.1 Argentina Pruritus Therapeutics Market by Disease Type
    • 7.2.2 Argentina Pruritus Therapeutics Market by Product
    • 7.2.3 Argentina Pruritus Therapeutics Market by Distribution Channel
  • 7.3 UAE Pruritus Therapeutics Market
    • 7.3.1 UAE Pruritus Therapeutics Market by Disease Type
    • 7.3.2 UAE Pruritus Therapeutics Market by Product
    • 7.3.3 UAE Pruritus Therapeutics Market by Distribution Channel
  • 7.4 Saudi Arabia Pruritus Therapeutics Market
    • 7.4.1 Saudi Arabia Pruritus Therapeutics Market by Disease Type
    • 7.4.2 Saudi Arabia Pruritus Therapeutics Market by Product
    • 7.4.3 Saudi Arabia Pruritus Therapeutics Market by Distribution Channel
  • 7.5 South Africa Pruritus Therapeutics Market
    • 7.5.1 South Africa Pruritus Therapeutics Market by Disease Type
    • 7.5.2 South Africa Pruritus Therapeutics Market by Product
    • 7.5.3 South Africa Pruritus Therapeutics Market by Distribution Channel
  • 7.6 Nigeria Pruritus Therapeutics Market
    • 7.6.1 Nigeria Pruritus Therapeutics Market by Disease Type
    • 7.6.2 Nigeria Pruritus Therapeutics Market by Product
    • 7.6.3 Nigeria Pruritus Therapeutics Market by Distribution Channel
  • 7.7 Rest of LAMEA Pruritus Therapeutics Market
    • 7.7.1 Rest of LAMEA Pruritus Therapeutics Market by Disease Type
    • 7.7.2 Rest of LAMEA Pruritus Therapeutics Market by Product
    • 7.7.3 Rest of LAMEA Pruritus Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 Bristol Myers Squibb Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Novartis AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Pfizer, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional & Segmental Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Approvals:
    • 8.3.6 SWOT Analysis
  • 8.4 Sanofi S.A.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 Astellas Pharma, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 SWOT Analysis
  • 8.6 Cara Therapeutics, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Research & Development Expenses
    • 8.6.4 Recent strategies and developments:
      • 8.6.4.1 Partnerships, Collaborations, and Agreements:
    • 8.6.5 SWOT Analysis
  • 8.7 GlaxoSmithKline PLC (GSK)
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Teva Pharmaceutical Industries Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Amgen, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 SWOT Analysis
  • 8.10. AbbVie, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Approvals & Trials:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 3 LAMEA Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 4 LAMEA Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 5 LAMEA Atopic Dermatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 6 LAMEA Atopic Dermatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 7 LAMEA Allergic Contact Dermatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Allergic Contact Dermatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Urticaria Market by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Urticaria Market by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Corticosteroids Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Corticosteroids Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Antihistamines Market by Country, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Local Anesthetics Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Local Anesthetics Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Counterirritants Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Counterirritants Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Immunosuppressant Market by Country, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Immunosuppressant Market by Country, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Calcineurin Inhibitors Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Calcineurin Inhibitors Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 33 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 34 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 35 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 36 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 37 LAMEA Pruritus Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 38 LAMEA Pruritus Therapeutics Market by Country, 2023 - 2030, USD Million
  • TABLE 39 Brazil Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 40 Brazil Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 41 Brazil Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 42 Brazil Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 43 Brazil Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 44 Brazil Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 45 Brazil Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 46 Brazil Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 47 Argentina Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 48 Argentina Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 49 Argentina Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 50 Argentina Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 51 Argentina Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 52 Argentina Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 53 Argentina Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 54 Argentina Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 55 UAE Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 56 UAE Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 57 UAE Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 58 UAE Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 59 UAE Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 60 UAE Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 61 UAE Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 62 UAE Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 63 Saudi Arabia Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 64 Saudi Arabia Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 65 Saudi Arabia Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 66 Saudi Arabia Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 67 Saudi Arabia Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 68 Saudi Arabia Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 69 Saudi Arabia Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 70 Saudi Arabia Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 71 South Africa Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 72 South Africa Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 73 South Africa Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 74 South Africa Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 75 South Africa Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 76 South Africa Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 77 South Africa Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 78 South Africa Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 79 Nigeria Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 80 Nigeria Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 81 Nigeria Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 82 Nigeria Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 83 Nigeria Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 84 Nigeria Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 85 Nigeria Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 86 Nigeria Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 87 Rest of LAMEA Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 88 Rest of LAMEA Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 89 Rest of LAMEA Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 90 Rest of LAMEA Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 91 Rest of LAMEA Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 92 Rest of LAMEA Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 93 Rest of LAMEA Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 94 Rest of LAMEA Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 95 Key Information - Bristol Myers Squibb Company
  • TABLE 96 Key Information - Novartis AG
  • TABLE 97 Key Information - Pfizer, Inc.
  • TABLE 98 Key Information - Sanofi S.A.
  • TABLE 99 key information - Astellas Pharma, Inc.
  • TABLE 100 Key Information - Cara Therapeutics, Inc.
  • TABLE 101 Key Information - GlaxoSmithKline PLC
  • TABLE 102 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 103 Key Information - Amgen, Inc.
  • TABLE 104 Key information - AbbVie, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 LAMEA Pruritus Therapeutics Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting Pruritus Therapeutics Market
  • FIG 4 Porter's Five Force Analysis: Pruritus Therapeutics Market
  • FIG 5 LAMEA Pruritus Therapeutics Market share by Disease Type, 2022
  • FIG 6 LAMEA Pruritus Therapeutics Market share by Disease Type, 2030
  • FIG 7 LAMEA Pruritus Therapeutics Market by Disease Type, 2019 - 2030, USD Million
  • FIG 8 LAMEA Pruritus Therapeutics Market share by Product, 2022
  • FIG 9 LAMEA Pruritus Therapeutics Market share by Product, 2030
  • FIG 10 LAMEA Pruritus Therapeutics Market by Product, 2019 - 2030, USD Million
  • FIG 11 LAMEA Pruritus Therapeutics Market share by Distribution Channel, 2022
  • FIG 12 LAMEA Pruritus Therapeutics Market share by Distribution Channel, 2030
  • FIG 13 LAMEA Pruritus Therapeutics Market by Distribution Channel, 2019 - 2030, USD Million
  • FIG 14 LAMEA Pruritus Therapeutics Market share by Country, 2022
  • FIG 15 LAMEA Pruritus Therapeutics Market share by Country, 2030
  • FIG 16 LAMEA Pruritus Therapeutics Market by Country, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: Bristol Myers Squibb Company
  • FIG 18 SWOT Analysis: Novartis AG
  • FIG 19 SWOT Analysis: Pfizer, Inc.
  • FIG 20 Swot Analysis: Sanofi S.A.
  • FIG 21 SWOT Analysis: Astellas Pharma, Inc.
  • FIG 22 SWOT Analysis: CARA THERAPEUTICS, INC.
  • FIG 23 SWOT Analysis: GlaxoSmithKline PLC
  • FIG 24 Swot Analysis: Teva Pharmaceuticals Industries Ltd.
  • FIG 25 Swot Analysis: Amgen, Inc.
  • FIG 26 Swot Analysis: AbbVie, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!